Response to the BRAF/MEK inhibitors dabrafenib/trametinib...

  • Main
  • 2018 / 01
  • Response to the BRAF/MEK inhibitors dabrafenib/trametinib...
Pediatric Blood & Cancer 2018 / 01

Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib

Marks, Asher M., Bindra, Ranjit S., DiLuna, Michael L., Huttner, Anita, Jairam, Vikram, Kahle, Kristopher T., Kieran, Mark W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Pediatric Blood & Cancer
DOI:
10.1002/pbc.26969
Date:
January, 2018
File:
PDF, 566 KB
english, 2018
Conversion to is in progress
Conversion to is failed